ABOUT HANKANG
漢康集團(tuán)
廣州匯英
- 分類：子公司介紹
- 發(fā)布時(shí)間：2023-06-13 10:55:06
- 訪問量：0
? 廣州匯英——原料藥、中間體解決方案提供
廣州匯英醫(yī)藥科技有限公司依托武漢海特和天津漢康兩大國內(nèi)頭部藥品研發(fā)與制造企業(yè)實(shí)力，聚焦國內(nèi)外CRO、CDMO業(yè)務(wù)與貿(mào)易合作，在人才、技術(shù)、經(jīng)驗(yàn)、國際市場方面擁有獨(dú)到的優(yōu)勢，能為市場提供藥物發(fā)現(xiàn)、CMC、臨床CRO、藥品注冊、CMO、CDMO等研發(fā)、生產(chǎn)全流程服務(wù)及一體化解決方案，并為市場提供國內(nèi)外高質(zhì)量的原料藥、中間體、雜質(zhì)、參比等。
聯(lián)系方式：
原料藥業(yè)務(wù)：+86 15620629054 / ivyding@drughk.com、+86 15521024601/ laishujie@drughk.com
參比制劑業(yè)務(wù)：+86 13512887913/ hunan@drughk.com
The introduction of Guangzhou Huiying Pharmaceutical Technology Co., Ltd
Guangzhou Huiying Pharmaceutical Technology Co., Ltd. is an important part of the five-in-one overall layout of Hankang Pharmaceutical Group in China and a bridgehead for domestic and international linkages.
Relying on two well-known domestic pharmaceutical companies, Hankang Pharmaceutical Group and Hiray Pharmaceutical (Jingmen) Co., Ltd., Huiying Pharmaceutical is based in South China and serves the world to help the development of China's pharmaceutical industry, improve the supply and security of domestic API, and integrate global API resources as the goal, give full play to its own resource advantages, customer advantages, talent advantages and technical advantages, relying on the research and development strength of high-end generic drugs and innovative drugs, assist cooperative enterprises to enhance their comprehensive competitiveness, improve drug research and development efficiency, and accelerate innovation Drugs are on the market and contribute to the cause of medicine and health.
In order to enhance the international market position of domestic enterprises and reduce the monopoly influence of foreign enterprises on the domestic API market, Huiying Pharmaceutical will focus on high-end raw materials and characteristic raw materials to carry out marketing business of domestic and foreign API, intermediates, impurities and RLD. At the same time, due to the pursuit of green and sustainable development, the domestic pharmaceutical industry is paying more and more attention to industrial upgrading, process improvement, and pollution treatment capabilities. For this reason, Huiying Pharmaceutical has the ability to assist partners in achieving green and sustainable development in the future to seize structural opportunities.
In addition, Huiying Pharmaceutical can also provide customers with CMO and CDMO services, assist customers in extending the industrial chain from API production to formulation production, and finally achieve transformation and upgrading.
In order to meet the needs of customers with high quality, Huiying Pharmaceutical has also established an open drug research and development service platform, which has "integrated, end-to-end" service capabilities, and can meet customer requirements in terms of technical depth and coverage. diverse needs. At the same time, relying on the rich technical reserves and project experience of headquarter, four major characteristic API, high-end API production bases and high-end formulation research platforms, Huiying Pharmaceutical can more efficiently coordinate upstream and downstream sectors and better empower cooperative companies .
In the future, Huiying Pharmaceutical will take solving industry problems and meeting customer needs as its own responsibility, creating more social and economic value for partners, and creating a better future together!
API business contact：
Ivy Ding +86 15620629054 / ivyding@drughk.com
Jay Lai +86 15521024601 / laishujie@drughk.com
RLD business contact：Hunan +86 13512887913 / hunan@drughk.com
